Article

The clinical spectrum of neuralgic amyotrophy in 246 cases

Department of Neurology, Neuromuscular Centre Nijmegen, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Brain (Impact Factor: 10.23). 03/2006; 129(Pt 2):438-50. DOI: 10.1093/brain/awh722
Source: PubMed

ABSTRACT We investigated the symptoms, course and prognosis of neuralgic amyotrophy (NA) in a large group of patients with idiopathic neuralgic amyotrophy (INA, n = 199) and hereditary neuralgic amyotrophy (HNA, n = 47) to gain more insight into the broad clinical spectrum of the disorder. Several findings from earlier smaller-scale studies were tested, and for the first time the potential differences between the hereditary and idiopathic phenotypes and between males and females were explored. Generally, the course of the pain manifests itself in three consecutive phases with an initial severe, continuous pain lasting for approximately 4 weeks on average. Sensory involvement was quite common and found in 78.4% of patients but was clinically less impairing than the initial pain and subsequent paresis. As a typically patchy disorder NA can affect almost any nerve in the brachial plexus, although damage in the upper and middle trunk distribution with involvement of the long thoracic and/or suprascapular nerve occurred most frequently (71.1%). We found no correlation between the distribution of motor and sensory symptoms. In INA recurrent attacks were found in 26.1% of the patients during an average 6 year follow-up. HNA patients had an earlier onset (28.4 versus 41.3 years), more attacks (mean 3.5 versus 1.5) and more frequent involvement of nerves outside the brachial plexus (55.8 versus 17.3%) than INA patients, and a more severe maximum paresis, with a subsequent poorer functional outcome. In males the initial pain tended to last longer than it did in females (45 versus 23 days). In females the middle or lower parts of the brachial plexus were involved more frequently (23.1 versus 10.5% in males), and their functional outcome was worse. Overall recovery was less favourable than usually assumed, with persisting pain and paresis in approximately two-thirds of the patients who were followed for 3 years or more.

Download full-text

Full-text

Available from: Baziel G Van Engelen, May 22, 2014
0 Followers
 · 
92 Views
  • Source
    • "PTS is typically characterized by a sudden onset of shoulder pain, followed by weakness and atrophy of the shoulder and proximal upper limb muscles (McCarty et al., 1999; Feinberg et al., 2006; Burca, 2009; Stutz, 2010). Sensory deficits may also occur (Cwik et al., 1990; van Alfen and van Engelen, 2006). The diagnosis (electroneuromyographic examination is the optimal method) involves identification of the affected nerve(s), associated muscles and sensory fields (Schreiber et al., 2009) for prognostic and treatment decision-making. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This study characterized the impairments of range of motion, three-dimensional scapulo-thoracic kinematics, isokinetic muscle performance and disability in a patient with Parsonage-Turner Syndrome. The patient had a history of 2.5-years of shoulder pain, and electroneurodiagnostic testing indicative of suprascapular neuropathy. The patient-rated Disabilities of the Arm, Shoulder and Hand (DASH) score was 33.3% (0 = no symptoms/disability), and reduced shoulder internal rotation, external rotation, and flexion as compared bilaterally. There were deficits in isokinetic muscle performance at slow and fast speeds during abduction, lateral and medial rotations as compared to the uninvolved side. Alterations in scapular kinematics were decreased posterior tilt, increased internal rotation, and increased upward rotation during arm elevation and lowering. This information can be used to assist clinicians in developing treatment programs to address the alterations caused by this neuralgic amyotrophy.
    Manual therapy 07/2013; DOI:10.1016/j.math.2013.06.004 · 1.76 Impact Factor
  • Source
    • "Une maladie de système (lupus ; périartérite noueuse), une infection peuvent être discutées. Les causes infectieuses apparaissent très diverses : tuberculose, typhoïde, yersiniose, leptospirose, variole, borréliose pour les affections bactériennes ; oreillons, herpès, CMV, EBV parvovirus B19 pour les affections virales [1]. La revue de la littérature des cas de syndrome de Parsonage–Turner rapportés au VIH, permet de discuter sept dossiers [2] [3] [4] [5] [6] ; l'atteinte serait plus volontiers bilatérale dans cette étiologie rétrovirale. "
    Médecine et Maladies Infectieuses 07/2012; 42(8):372-3. DOI:10.1016/j.medmal.2012.06.004 · 0.91 Impact Factor
  • Source
    • "Abrupt onset of severe shoulder pain followed by weakness and wasting of several shoulder muscles is the typical clinical picture. The exact cause is unknown, although risk factors are found in more than half the cases [2]. Infectious agents are among the main suggested culprits. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Parsonage-Turner syndrome, also known as acute brachial neuritis or neuralgic amyotrophy, can be caused by various infectious agents. We report on four patients who experienced Parsonage-Turner syndrome as the first manifestation of Lyme disease. The clinical picture was typical, with acute shoulder pain followed rapidly by weakness and wasting of the shoulder girdle muscles. Electrophysiological testing showed denervation. A single patient reported erythema chronicum migrans after a tick bite. Examination of the cerebrospinal fluid showed lymphocytosis and protein elevation in 3 patients. Serological tests for Lyme disease were positive in the serum in all 4 patients and in the cerebrospinal fluid in 2 patients. Antibiotic therapy ensured a favorable outcome in all 4 cases. Two patients achieved a full recovery within 6 months. Parsonage-Turner syndrome should be added to the list of manifestations of neuroborreliosis. Serological tests for Lyme disease should be performed routinely in patients with Parsonage-Turner syndrome.
    Joint, bone, spine: revue du rhumatisme 02/2009; 76(2):202-4. DOI:10.1016/j.jbspin.2008.07.013 · 3.22 Impact Factor
Show more